StartCRL • NYSE
add
Charles River Laboratories
Seneste lukkekurs
177,85 $
Dagsinterval
160,01 $ - 180,19 $
Årsinterval
91,86 $ - 230,02 $
Markedsværdi
8,06 mia. USD
Gns. volumen
1,02 mio.
P/E-værdi
-
Udbytteprocent
-
Primær børs
NYSE
I nyhederne
Økonomi
Resultatopgørelse
Indtægt
Nettoindtægt
| (USD) | jun. 2025info | År til år-ændring |
|---|---|---|
Indtægt | 1,03 mia. | 0,59 % |
Driftsudgifter | 211,51 mio. | 8,67 % |
Nettoindtægt | 52,33 mio. | -44,38 % |
Overskudsgrad | 5,07 | -44,71 % |
Earnings per share | 3,12 | 11,43 % |
EBITDA | 327,04 mio. | 26,18 % |
Effektiv afgiftssats | 26,22 % | — |
Årsbalance
Samlede aktiver
Samlede passiver
| (USD) | jun. 2025info | År til år-ændring |
|---|---|---|
Kontanter og korttidsinvesteringer | 182,82 mio. | 2,01 % |
Samlede aktiver | 7,56 mia. | -4,88 % |
Samlede passiver | 4,16 mia. | -0,34 % |
Samlet egenkapital | 3,40 mia. | — |
Shares outstanding | 49,21 mio. | — |
Kurs/indre værdi | 2,61 | — |
Afkast af aktiver | 5,68 % | — |
Afkast af kapital | 6,93 % | — |
Pengestrøm
Nettoændring i likviditet
| (USD) | jun. 2025info | År til år-ændring |
|---|---|---|
Nettoindtægt | 52,33 mio. | -44,38 % |
Pengestrøm fra drift | 204,60 mio. | 5,72 % |
Pengestrøm fra investering | -37,34 mio. | 39,65 % |
Pengestrøm fra finansiering | -226,92 mio. | 20,62 % |
Nettoændring i likviditet | -46,99 mio. | 70,17 % |
Fri pengestrøm | 228,38 mio. | 54,82 % |
Om
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Administrerende direktør
Grundlagt
1947
Hovedkvarter
Website
Ansatte
19.400